What is Vpriv?
Vpriv is the brand name for velaglucerase alfa, an enzyme replacement therapy used to treat Gaucher disease [1].
What type of Gaucher disease does Vpriv treat?
Vpriv is used for Gaucher disease in people who need enzyme replacement therapy; it’s commonly associated with Type 1 Gaucher disease (the non-neuronopathic form) [1].
How does Vpriv work?
Gaucher disease is caused by a deficiency of an enzyme needed to break down certain fatty substances. Vpriv provides a working form of that enzyme (velaglucerase alfa), helping reduce the buildup that drives symptoms [1].
How is Vpriv given?
Vpriv is administered as an intravenous (IV) infusion in a healthcare setting [1].
What side effects are associated with Vpriv?
Commonly reported adverse effects for enzyme replacement therapies like Vpriv can include infusion-related reactions (the specific side effect profile depends on the patient and treatment course) [1].
Who makes Vpriv?
Vpriv is manufactured by Takeda [1].
Is Vpriv the only enzyme replacement option?
No. Patients can be treated with other enzyme replacement therapies depending on availability and clinical judgment. If you want, tell me your country and whether this is for adult or pediatric use, and I can help compare options at a high level.
Sources
- https://www.drugs.com/vpriv.html